![Jason Adair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Adair
Investor Relations Kontakt bei
LIQUIDIA CORPORATION
Vermögen: 12 Mio $ am 31.08.2026
Profil
Jason Adair is Vice President-Corporate Development & Strategy at Liquidia Technologies, Inc. since 2016.
Mr. Adair is Chief Business Officer & Head-Investor Relations at Liquidia Corp.
since 2016.
Formerly, Mr. Adair was Executive Director-Corporate Development at BioCryst Pharmaceuticals, Inc. from 2011 to 2015.
Mr. Adair also served as Vice President-Corporate Development & Strategy at Liquidia Corp.
Education includes an undergraduate degree from Wake Forest University and an MBA from Tuck School of Business at Dartmouth.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,2 % | 21.08.2026 | 174.606 ( 0,2 % ) | 12 Mio $ | 31.08.2026 |
Aktive Positionen von Jason Adair
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Investor Relations Kontakt | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Corporate Officer/Principal | 14.01.2016 |
Ehemalige bekannte Positionen von Jason Adair
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2015 |
| LIQUIDIA CORPORATION | Investor Relations Kontakt | - |
Ausbildung von Jason Adair
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
